Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis. (Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015)